Companies: 10,795·Total market cap: $144.5T
Genenta Science S.p.A.

Genenta Science S.p.A.

GNTANASDAQHealthcare● Active
$1.80
+$0.00(+0.13%)
Market Cap$34507679
P/E Ratio
52W High$10
52W Low$0.55

Genenta Science S.p.A. (GNTA) Revenue

Annual & quarterly revenue history · segment & region breakdown

GNTA · revenue · updated Jun 10, 2026

Core revenue metrics

Genenta Science S.p.A. trailing twelve-month (TTM) revenue is $0.00B, an increase of 0.00% year-over-year from — in FY.

TTM revenue
$0.00B
4-quarter sum · USD
YoY growth
+0.00%
vs FY
Price / sales
mktCap ÷ TTM rev
Revenue per day
Est. TTM ÷ 365
Revenue / employee
$0K
13 employees
FY
FY
5Y CAGR
Fiscal year end
Dec 31
Currency
USD · GAAP
Filing
10-K / 10-Q
Source: FMP · Genenta Science S.p.A. SEC filings · GAAPUpdated: 2026-06-10

Revenue trend

· Annual
YoY revenue growth %
revenue trend · revenue chart · revenue by year · revenue history

Revenue history

Fiscal year endRevenueChangeGrowth
GNTA revenue by year · GNTA revenue history · GNTA annual revenue data

About Revenue & Reporting

Revenue (also called sales, net sales, or turnover) is the total income Genenta Science S.p.A. receives from its business operations before deducting any costs or expenses. It is the top line of the income statement. Unlike net income or earnings, revenue does not account for operating costs, taxes, interest, or depreciation.

Genenta Science S.p.A. reports revenue on a fiscal year ending Dec 31 basis under US GAAP, denominated in USD.

Data sourced from Genenta Science S.p.A.'s 10-K and 10-Q SEC filings via Financial Modeling Prep.

Figures tie to SEC 10-K/10-Q and FMP income-statement endpoints where noted.

Frequently asked questions

GNTA revenue · 4 questions

GNTA's trailing twelve-month (TTM) revenue is $0.00B. That is an increase of 0.00% year-over-year from — in FY.

GNTA revenueGNTA annual revenuewhat is GNTA revenueGNTA TTM revenue

Source: FMP · Genenta Science S.p.A. SEC filings · GAAP · Genenta Science S.p.A. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 10, 2026